Abstract
AbstractThis case describes the management of a plexiform unicystic ameloblastoma in a child with cardiofaciocutaneous syndrome. This was managed conservatively, which has allowed the patient to undergo normal dental development. There are no signs of recurrence 4 years post‐operatively and the use of magnetic resonance imaging in monitoring has ensured the patient's exposure to ionising radiation is minimised. The patient's cardiofaciocutaneous syndrome was linked to a BRAF mutation. This gene is involved in cell proliferation and has recently been shown to have a link with mandibular ameloblastomas. As far as the authors are aware, this is the published first case of an ameloblastoma in a patient with cardiofaciocutaneous syndrome.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
